Avita Medical
RCEL
#7357
Rank
C$0.44 B
Marketcap
$16.84
Share price
-5.01%
Change (1 day)
-4.77%
Change (1 year)
Categories

P/E ratio for Avita Medical (RCEL)

P/E ratio as of November 2024 (TTM): -6.30

According to Avita Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.2973. At the end of 2021 the company had a P/E ratio of -11.6.

P/E ratio history for Avita Medical from 2020 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2021-11.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-8.88 41.00% Jersey
-0.9868-84.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.1617-97.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.69-57.23%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.